Opportunity ID: 300306

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-18-594
Funding Opportunity Title: NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.846 — Arthritis, Musculoskeletal and Skin Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jan 26, 2018
Last Updated Date:
Original Closing Date for Applications: Nov 03, 2020
Current Closing Date for Applications: Nov 03, 2020
Archive Date: Dec 09, 2020
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: State governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal organizations (other than Federally recognized tribal governments)
Small businesses
Independent school districts
County governments
Private institutions of higher education
Special district governments
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) invites cooperative agreement (U01) applications for implementation of investigator-initiated interventional clinical trials (all phases). Applications for clinical trials submitted to the NIAMS are normally expected to go through a two-part process, which begins with an R34 planning phase (Part 1) followed by an application for the U01 (Part 2). Investigators who have completed all necessary pre-trial planning and preparation through other means may apply for a NIAMS U01 without having applied for a R34. The NIAMS expects such trials to be hypothesis driven, milestone-defined, and have the potential for high impact within the research mission of the NIAMS.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-18-594.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00237874 Feb 27, 2018 May 24, 2020 View
FORMS-F Use for due dates on or after May 25, 2020 PKG00259513 Feb 27, 2018 Nov 03, 2020 View

Package 1

Mandatory forms

300306 RR_SF424_2_0-2.0.pdf

300306 PHS398_CoverPageSupplement_4_0-4.0.pdf

300306 RR_OtherProjectInfo_1_4-1.4.pdf

300306 PerformanceSite_2_0-2.0.pdf

300306 RR_KeyPersonExpanded_2_0-2.0.pdf

300306 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

300306 RR_Budget_1_4-1.4.pdf

300306 RR_SubawardBudget30_1_4-1.4.pdf

300306 PHS398_ModularBudget_1_2-1.2.pdf

300306 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

300306 RR_SF424_2_0-2.0.pdf

300306 PHS398_CoverPageSupplement_5_0-5.0.pdf

300306 RR_OtherProjectInfo_1_4-1.4.pdf

300306 PerformanceSite_2_0-2.0.pdf

300306 RR_KeyPersonExpanded_2_0-2.0.pdf

300306 PHS398_ResearchPlan_4_0-4.0.pdf

300306 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

300306 RR_Budget_1_4-1.4.pdf

300306 RR_SubawardBudget30_1_4-1.4.pdf

300306 PHS398_ModularBudget_1_2-1.2.pdf

300306 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T09:44:45-05:00

Share This Post, Choose Your Platform!

About the Author: